The United States of America, as represented by the Secretary, Department of Health and Human Services;Kite Pharma; Inc.;Kite Pharma, Inc.
发明人:
Bot, Adrian,Go, William,Jain, Rajul,Wiezorek, Jeffrey S.,Kochenderfer, James N.,Rosenberg, Steven A.
申请号：
AU2016268864
公开号：
AU2016268864A1
申请日:
2016.05.27
申请国别(地区):
AU
年份:
2017
代理人:
摘要：
The invention provides methods of increasing the efficacy of a T cell therapy in a patient in need thereof. The invention includes a method of conditioning a patient prior to a T cell therapy, wherein the conditioning involves administering a combination of cyclophosphamide and fludarabine.
